Sensing by intrahepatic muscarinic nerves of a portal-arterial glucose concentration gradient as a signal for insulin-dependent glucose uptake in the perfused rat liver  by Stümpel, Frank & Jungermann, Kurt
FEBS 18399 FEBS Letters 406 (1997) 119-122 
Sensing by intrahepatic muscarinic nerves of a portal-arterial glucose 
concentration gradient as a signal for insulin-dependent glucose uptake in 
the perfused rat liver 
Frank Stiimpel*, Kurt Jungermann 
Institut fur Biochemie und Molekulare Zellbiologie, Georg-August-Universitdt, Humboldtallee 23, 37073 Gottingen, Germany 
Received 15 February 1997 
Abstract In vivo, insulin increases net hepatic glucose uptake 
efficiently only in the presence of a portal-arterial glucose 
gradient. In isolated perfused rat livers supplied with a glucose 
gradient (portal 10 mM/arterial 5 mM) insulin-induced glucose 
uptake was blocked by atropine; in livers not supplied with the 
gradient (portal = arterial 5 mM) insulin-dependent glucose 
uptake was elicited by acetylcholine. Apparently, the gradient 
was sensed and transformed into a metabolic signal by 
intrahepatic nerves, releasing acetylcholine to muscarinic recep-
tors. 
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Key words: Liver metabolism; Insulin; Bivascular liver 
perfusion; Muscarinic nerve 
1. Introduction 
The liver is the glucostat of the organism; it takes up in-
gested carbohydrates and stores them as glycogen in the ab-
sorptive state and releases glucose to maintain euglycemia in 
the postabsorptive state. Insulin is generally accepted to be the 
hormone inducing net hepatic glucose uptake and storage into 
glycogen [1]. However, when glucose was applied via a periph-
eral vein, even high insulin concentrations failed to induce 
substantial net hepatic glucose uptake in man [2] as well as 
in dogs [3]. When instead glucose was given orally, infusion of 
insulin induced a marked net hepatic glucose uptake in man 
[4] and in dogs [3,5]. An explanation for this lack of effect of 
insulin on hepatic glucose metabolism with peripheral glucose 
infusion could not be given but it was argued that a glucose 
gradient between the portal vein and the hepatic artery rather 
than the absolute concentration of glucose might be involved 
in the regulation of hepatic glucose metabolism. This was 
demonstrated in vivo with the so called pancreatic clamp in 
dogs [3] and in vitro with isolated rat liver bivascularly per-
fused via both the portal vein and hepatic artery [6]. When a 
glucose concentration gradient was established with a higher 
concentration in the portal vein, insulin was able to induce net 
hepatic glucose uptake. When an inverse gradient with a high-
er glucose concentration in the hepatic artery was offered, 
insulin was unable to elicit a net hepatic glucose uptake [6]. 
However, the mechanisms of sensing a portal-arterial glucose 
gradient and of transmitting a metabolic signal to the hepa-
tocytes have remained unknown so far. 
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Since the liver is richly innervated [7-9] and glucose recep-
tors have been demonstrated electrophysiologically in the por-
tal region of guinea pig liver [10], the hepatic nervous system 
might be involved in the possible signal chain. This was sup-
ported by in vivo data in dogs which had undergone surgical 
hepatic denervation: insulin no longer stimulated net hepatic 
glucose uptake [11]. 
Therefore, it was the aim of the present investigation to 
examine the possible role of hepatic nerves in sensing a portal 
arterial glucose concentration gradient and in rendering hep-
atic glucose uptake insulin-sensitive with isolated, bivascularly 
perfused rat liver. 
2. Materials and methods 
2.1. Materials and animals 
All chemicals were of reagent grade and from commercial sources. 
Enzymes and bovine serum albumin were purchased from Boehringer 
(Mannheim, Germany). Insulin, atropine and acetylcholine were ob-
tained from Sigma (Munich, Germany). Male Wistar rats were kept 
on a day-night rhythm (7 a.m.-7 p.m.) with ad lib feeding. 
2.2. Liver perfusion 
All perfusion experiments were started at 9 a.m. The liver was 
perfused in situ without recirculation via both the portal vein with 
low pressure (10 mm Hg [1.33 kPa], 80-60% of total flow) and the 
hepatic artery with high pressure (60-70 mm Hg [7.89-9.31 kPa], 20-
40% of total flow) resulting in a total flow of about 4 ml min - 1 g 
organ weight-1 as described in detail elsewhere [6]. The basic perfu-
sion medium was an erythrocyte-free Krebs-Henseleit-bicarbonate 
buffer containing 5 mmol/1 glucose, 2 mmol/1 lactate, 0.2 mmol/1 pyr-
uvate and 0.5% bovine serum albumin. As indicated, in some experi-
ments the glucose concentration of the portal and/or arterial perfusion 
medium was 10 mmol/1. The medium was equilibrated with C>2:C02 
(19:1). 
Experiments were started following a pre-perfusion period of 20 
min. Perfusion buffer samples were taken consecutively at 1 min in-
tervals and directly cooled on ice. Metabolite concentrations were 
measured with standard enzymatic techniques as described before 
[6]. Total perfusion flow was quantified by fractionating the effluate 
into calibrated tubes. The portal flow was measured with an SMS-302 
electromagnetic flow meter (Hellige, Freiburg, Germany) placed 
around the portal inflow. The arterial flow was calculated as the 
difference between total and portal flow. 
2.3. Infusion of insulin, atropine and acetylcholine 
Insulin was infused into the portal vein diluted in the perfusion 
buffer containing 0.5% bovine serum albumin to the indicated final 
sinusoidal concentrations. Atropine and acetylcholine were infused via 
the portal vein or hepatic artery diluted to the appropriate sinusoidal 
concentrations indicated. 
3. Results 
Isolated livers were perfused with medium containing a high 
glucose concentration (10 mmol/1) via both the portal vein 
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Fig. 1. The insulin-stimulated net hepatic glucose uptake in the presence of a portal-arterial glucose concentration gradient can be blocked by 
portal or arterial atropine. Livers were perfused via both the portal vein and hepatic artery without recirculation with a Krebs-Henseleit bicar-
bonate buffer containing 5 or 10 mmol/1 glucose as indicated in the lower left inset in each panel, 2 mmol/1 lactate, 0.2 mmol/1 pyruvate and 
0.5% bovine serum albumin. Insulin (100 nmol/1) was infused via the portal vein and atropine (1 nmol/1) via the portal vein or hepatic artery 
when indicated. Values are means ±S.E.M. of the number of experiments given in parentheses, po, portal; a, arterial. 
(PV) and the hepatic artery (HA), i.e. a glucose load of 40 
umol min - 1 g_ 1. During the pre-perfusion period without 
portal insulin infusion the hepatic glucose balance remained 
unchanged at a basal glucose output of about 0.5 trmol min- 1 
g_ 1 organ weight (Fig. 1A). From min 31 onwards, insulin 
(100 nmol/1) infused into the PV caused a slight decrease in 
basal glucose output but did not stimulate net hepatic glucose 
uptake (Fig. 1A). However, when a portal-arterial glucose 
concentration gradient was established first (PV 10 mmol/1, 
HA 5 mmol/1) resulting in a glucose load of 33 itmol min- 1 
g_1, portal insulin induced a marked hepatic glucose uptake 
(Fig. IB). Basal glucose output shifted from 0.5 |a,mol min- 1 
g_ 1 to uptake of about 1.5 u.mol min- 1 g_ 1 ; the maximum of 
the effect was reached within 20 min. 
When as a control livers were perfused with an inverse 
concentration gradient (PV 5 mmol/1, HA 10 mmol/1 glucose) 
30 40 50 30 40 50 30 40 50 
Time (min) 
40 50 40 50 
Fig. 2. The portal-arterial glucose concentration gradient is mimicked by portal or arterial acetylcholine. Livers were perfused via both the por-
tal vein and hepatic artery without recirculation with a Krebs-Henseleit bicarbonate buffer containing 5 mmol/1 glucose as indicated in the low-
er left inset in each panel, 2 mmol/1 lactate, 0.2 mmol/1 pyruvate and 0.5% bovine serum albumin. The glucose concentration in the portal vein 
was raised from 5 to 10 mmol/1 in series E from min 36 onwards. Insulin (100 nmol/1) was infused via the portal vein and acetylcholine (1 
umol/1) via the portal vein or hepatic artery when indicated. Values are means ± S.E.M. of the number of experiments given in parentheses, po, 
portal; a, arterial. 
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Fig. 3. Hypothetical scheme of the regulatory circuit of sensing and transmitting a glucose concentration gradient to the hepatocytes. If a nerve 
cell senses a glucose concentration gradient between the portal vein and hepatic artery it releases acetylcholine to a muscarinic receptor. This 
signal is permissive for insulin action on glucose uptake. The function of sensing the gradient is to distinguish between exogenous glucose from 
food (po>a) and endogenous glucose (po = a) generated mainly within the liver itself. Ins, insulin; InsR, insulin receptor; mACH-R, muscar-
inic receptor; ACH, acetylcholine; HA, hepatic artery; PV, portal vein. 
resulting in a glucose load of 27 umol min- 1 g~\ basal glu-
cose output equalled that of livers offered the higher glucose 
load without a gradient or the sightly higher glucose load with 
the normal portal-arterial glucose gradient; with the inverse 
glucose gradient portal insulin did not cause any change in 
hepatic glucose balance even after 20 min (Fig. 1C). 
To evaluate the role of hepatic nerves livers were perfused 
with the normal glucose gradient and the normal load of 33 
umol min- 1 g_1. A portal infusion of atropine (1 nmol/1) was 
then started 5 min prior to the portal infusion of insulin. 
Within these 5 min atropine did not significantly alter basal 
hepatic glucose output. However, it significantly decreased the 
insulin-induced net hepatic glucose uptake from a maximum 
of 1.5 to only 0.25 umol min- 1 g_ 1 (Fig. ID). Infusion of 
atropine into the hepatic artery caused a virtually identical 
inhibition of net hepatic glucose uptake (Fig. IE). Apparently, 
muscarinic cholinergic nerves were involved in sensing the 
glucose concentration gradient and transforming it into a met-
abolic signal for the hepatocytes. 
If this were the case, it should be possible to mimic the 
glucose concentration gradient at least in part by infusing 
acetylcholine into the portal vein or the hepatic artery. With 
a low glucose load of 20 umol min- 1 g_ 1 offered without a 
gradient (PV 5 mmol/1, HA 5 mmol/1), basal hepatic glucose 
output was not significantly different from that observed with 
the higher glucose load without a glucose gradient (PV 10 
mmol/1, HA 10 mmol/1) or with the normal glucose load 
with a normal glucose gradient (PV 10 mmol/1, HA 5 mmol/ 
1); it amounted to about 0.4 umol min- 1 g_ 1 (Fig. 2A vs. Fig. 
1A,B). With the infusion of portal insulin no significant re-
duction in basal glucose output could be detected (Fig. 2A). 
Portal infusion of acetylcholine (1 umol/1) alone did not cause 
a significant alteration in basal hepatic glucose output either, 
even after 20 min (Fig. 2B). However, portal infusion of ace-
tylcholine in the presence of portal insulin infusion resulted in 
a shift to net hepatic glucose uptake with a maximum of 1.2 
umol min- 1 g_ 1 (Fig. 2C). Arterial infusion of acetylcholine 
resulted in an identical shift to net hepatic glucose uptake 
when compared with portal acetylcholine (Fig. 2D). When 
in the presence of portal insulin the normal portal-arterial 
glucose concentration gradient was established instead of a 
portal acetylcholine infusion by elevating the portal glucose 
concentration to 10 mmol/1, again a shift to net hepatic glu-
cose uptake of about 1.3 umol min- 1 g_ 1 was observed (Fig. 
2E). 
4. Discussion 
4.1. Importance of a portal arterial glucose concentration 
gradient for net hepatic glucose uptake 
In the present investigation it was shown that in the isolated 
hemoglobin-free perfused rat liver insulin stimulated net hep-
atic glucose uptake only in the presence of a portal-arterial 
glucose concentration gradient (with the higher glucose con-
centration in the PV) (Fig. IB). These data are in accord with 
the results of a previous study in which the importance of a 
portal-arterial glucose concentration gradient for insulin-de-
pendent net hepatic glucose uptake was demonstrated in the 
isolated rat liver perfused with erythrocyte-containing me-
dium; the amount of glucose taken up was approximately 
the same [6]. This is in agreement with in vivo experiments 
in dogs in which the combination of experimental hypergly-
cemia without a portal-arterial glucose concentration gradient 
(induced by peripheral glucose infusion) and hyperinsulinemia 
caused only a weak net hepatic glucose uptake [3,11]. How-
ever, net hepatic glucose uptake more than doubled in hu-
mans [2] and conscious dogs [3] when hyperglycemia with a 
portal-arterial glucose concentration gradient and hyperinsu-
linemia were combined. In addition, it was demonstrated that 
the magnitude of net hepatic glucose uptake correlated with 
the magnitude of the portal-arterial glucose concentration 
gradient [11]. Thus, the importance of a portal-arterial glucose 
concentration gradient for an insulin-stimulated net hepatic 
glucose uptake is well established. 
4.2. Involvement of intrahepatic nerves 
The question remained how hepatic glucose uptake by the 
hepatocytes was rendered insulin-sensitive, since the cells are 
positioned in the sinusoidal blood composed of both portal 
and arterial blood. They are therefore unable to differentiate 
between glucose that was delivered by the portal vein or the 
hepatic artery. Thus, the glucose concentration in the portal 
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vein and for comparison in the hepatic artery (or elsewhere in 
any other artery) must be sensed and the difference must be 
transformed into a metabolic signal transmitted to the hepa-
tocytes. One possible mechanism could involve the hepatic 
nervous system. In the present investigation with isolated per-
fused rat liver the insulin-stimulated glucose uptake at a nor-
mal postprandial glucose load (33 umol min - 1 g_1) in the 
presence of a portal-arterial glucose concentration gradient 
was markedly reduced by either portal or arterial atropine 
(Fig. 1D,E). Moreover, when at a lower postabsorptive glu-
cose load (20 umol min - 1 g_1) without a glucose gradient 
insulin was infused together with either portal or arterial ace-
tylcholine, a substantial net hepatic glucose uptake was eli-
cited (Fig. 2C,D). Thus, a portal-arterial glucose gradient 
could be mimicked by portal or arterial acetylcholine. These 
two observations strongly indicated that intrahepatic nerves 
of the hepatoportal area were involved in allowing the stim-
ulation of net hepatic glucose uptake by insulin. On the as-
sumption that intrahepatic nerves deteriorate following liver 
denervation, the present results are in accord with previous in 
vivo studies in which dogs were subjected to surgical hepatic 
denervation and the insulin-dependent response to a portal 
glucose delivery was completely lost [11]. Moreover, the 
present observations are in line with a general link between 
insulin action and cholinergic nerves as shown recently in cats 
in vivo using the euglycemic clamp technique: portal atropine 
caused insulin resistance [12]. Finally, the present findings ex-
plain the observation that in the isolated liver perfused clas-
sically via the portal vein only infusion of insulin and acetyl-
choline but not of insulin or acetylcholine alone resulted in an 
increase in liver glycogen content [13]. 
The liver and portal vein are richly innervated by sympa-
thetic and parasympathetic, efferent and afferent nerves [7-9]; 
90% of the nerve fibers of the hepatic vagus were estimated to 
be afferent, indicating important sensory functions of the hep-
atoportal area. Glucose receptors have been demonstrated 
electrophysiologically in the portal vein [10]. Although func-
tional results indicate the existence of muscarinic receptors in 
the liver [14,15], they have not been shown directly on liver 
parenchymal or non-parenchymal cells. However, the pro-
posed muscarinic receptor must be located downstream of 
the confluence of portal and arterial blood since portal as 
well as arterial acetylcholine could mimic the portal-arterial 
glucose concentration gradient. The mechanism of sensing the 
glucose gradient and generating a metabolic signal for the 
hepatocytes was still functional in isolated rat liver prepara-
tions [6], therefore it is clear that these systems contained at 
least the minimum of elements required for the signal chain. A 
hypothetical scheme of the regulatory circuit can be proposed 
(Fig. 3): a sensory nerve cell monitors the glucose concentra-
tions in the portal vein and hepatic artery; when a concen-
tration gradient with the higher concentration in the portal 
vein is measured, a signal to the hepatocytes is generated and 
transmitted via muscarinic nerves. 
4.3. Possible physiological role 
The current opinion is that the liver in the postabsorptive 
state releases glucose if required by extrahepatic organs and in 
the absorptive state removes a substantial part of the excess 
glucose following the intake of a carbohydrate-rich meal. As a 
result of the absorption of glucose the concentration in the 
draining vessel (the portal vein) would rise and a portal-arte-
rial glucose concentration gradient would be established. With 
the sensing of a portal-arterial glucose gradient the liver 
would be able to distinguish between endogenous and exoge-
nous glucose and glucose uptake by the hepatocytes would be 
rendered insulin-sensitive only when a concentration gradient 
signals the appearance of exogenous glucose. 
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